Last reviewed · How we verify
NCT03180320: BESMILE-HF
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NA trial testing BESMILE-HF program in Heart Failure NYHA Class II in 150 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Guangdong Provincial Hospital of Traditional Chinese Medicine |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 22 October 2018 |
| Primary completion | 31 December 2025 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- BESMILE-HF program
- Usual medications — full drug profile →
Conditions studied
- Heart Failure NYHA Class II — all drugs for Heart Failure NYHA Class II →
- Heart Failure NYHA Class III — all drugs for Heart Failure NYHA Class III →
- Heart Failure — all drugs for Heart Failure →
Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Who can join
18 and older, any sex, with Heart Failure NYHA Class II or Heart Failure NYHA Class III. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic heart failure (CHF) is a major and growing public health problem and poses economic burden on the society. There is a need for a safe, equipment-free, low-cost, and easily implemented exercise-based cardiac rehabilitation program for CHF patients in China. Baduanjin exercise, translated as 'eight silken movements', is one of the most common forms of traditional Chinese exercise and it could have value to be integrated into a exercise-based cardiac rehabilitation program for CHF patients, together with education, evaluation and consultancy. Accordingly, the BESMILE-HF program applying the Baduanjin exercise as the central component, has been developed in Guangdong Provincial Hospital of Chinese Medicine which is one of the largest hospitals of Chinese medicine in China. This project is to evaluate the efficacy and acceptability of BESMILE-HF program in patients with CHF in China, and it will be based on a randomized controlled trial and a qualitative study.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effect of an exercise-based cardiac rehabilitation program "Baduanjin Eight-Silken-Movements with self-efficacy building" for heart failure (BESMILE-HF study): study protocol for a randomized controlled trial.
Chen X, Jiang W, Lin X, Lundborg CS, et al · · 2018 · cited 16× · PMID 29490680 · DOI 10.1186/s13063-018-2531-9 -
Feasibility and Preliminary Effects of the BESMILE-HF Program on Chronic Heart Failure Patients: A Pilot Randomized Controlled Trial.
Chen X, Jiang W, Olson TP, Lundborg CS, et al · · 2021 · cited 8× · PMID 34386535 · DOI 10.3389/fcvm.2021.715207 -
Traditional <i>Baduanjin</i> exercise through the eyes of patients with chronic heart failure: A qualitative content analysis study.
Chen X, Jiang W, Salazar M, Zhu H, et al · · 2022 · cited 5× · PMID 36684583 · DOI 10.3389/fcvm.2022.1049036 -
Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers.
Sun P, Cen H, Chen S, Chen X, et al · · 2023 · cited 4× · PMID 36894879 · DOI 10.1186/s12872-023-03127-9 -
Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography.
Cen H, Chen S, Feng S, Chen X, et al · · 2024 · cited 2× · PMID 39219247 · DOI 10.1002/ehf2.15038 -
Left Atrial Reservoir Longitudinal Strain is a Resting Marker of Exercise Capacity in Chronic Heart Failure: A Cross-sectional Study
Sun P, Cen H, Chen S, Chen X, et al · · 2021 · DOI 10.21203/rs.3.rs-991212/v1
Verify or expand the search:
- PubMed search for NCT03180320
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure NYHA Class II
Currently open trials in the same condition.
- NCT05632432 — Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery · NA · recruiting
- NCT04829617 — Promoting Well-being and Health in Heart Failure · NA · recruiting
Other Guangdong Provincial Hospital of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07352137 — Endoscopic Nipple-Sparing Mastectomy (E-NSM) With Immediate Multistage Autologous Fat Grafting(IMAFG) for Total Breast R · NA · enrolling by invitation
- NCT06908473 — Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients · Phase 3 · enrolling by invitation
- NCT06328153 — Efficacy and Mechanism of FSN Treatment for Senile Knee Osteoarthritis · NA · unknown
- NCT06166121 — Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules · NA · unknown
- NCT06001112 — Immediate Analgesic Effects of Cheek Acupuncture for Acute Gouty Arthritis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03180320 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangdong Provincial Hospital of Traditional Chinese Medicine
- Last refreshed: 18 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03180320.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing